Literature DB >> 2438939

Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?

N Willcox, M Schluep, M A Ritter, H J Schuurman, J Newsom-Davis, B Christensson.   

Abstract

The authors report an immunohistologic study of primary thymomas from 23 cases with myasthenia gravis (MG) and 7 without. Typical T6+ cortical thymocytes were usually abundant. Most epithelial cells initially appeared to be of cortical type, too, though many bore subcapsular markers in most samples. However, two-color immunofluorescence revealed unexpected heterogeneity, numerous epithelial cells simultaneously expressing some or all of the markers of both these subsets (even in two pleural metastases). It is inferred that there is a common tumor stem cell whose normal counterpart may be related to the rare patches of similar phenotype in the cortex in control samples. The authors could detect no major differences in 5 of 7 samples from nonmyasthenics; thus, most thymoma cases may risk the development of MG. Finally, thymomas from 6 of 7 further MG cases pretreated with corticosteroids showed very few cortical thymocytes, and the (phenotypically similar) epithelium was more obvious.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438939      PMCID: PMC1899778     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  REACTIVITY OF MYASTHENIA GRAVIS SERUM GAMMA-GLOBULIN WITH SKELETAL MUSCLE AND THYMUS DEMONSTRATED BY IMMUNOFLUORESCENCE.

Authors:  H VAN DER GELD; T E FELTKAMP; H J OOSTERHUIS
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

Review 2.  The spectrum of diseases associated with thymoma. Coincidence or syndrome?

Authors:  J V Souadjian; P Enriquez; M N Silverstein; J M Pépin
Journal:  Arch Intern Med       Date:  1974-08

Review 3.  The syndrome of thymoma and erythroblastopenic anemia. A review of 56 cases including 3 case reports.

Authors:  E Hirst; T I Robertson
Journal:  Medicine (Baltimore)       Date:  1967-05       Impact factor: 1.889

4.  Gm allotypes in myasthenia gravis.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; H Nishitani; K Ota; T Fujita; K Tsuji
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

5.  Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy.

Authors:  T Namba; N G Brunner; D Grob
Journal:  Medicine (Baltimore)       Date:  1978-09       Impact factor: 1.889

Review 6.  Immunology of acetylcholine receptors in relation to myasthenia gravis.

Authors:  A Vincent
Journal:  Physiol Rev       Date:  1980-07       Impact factor: 37.312

Review 7.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

8.  Subpopulations of lymphocytes in human thymomas.

Authors:  L Lauriola; M Piantelli; A Carbone; M A Dina; C Scoppetta; P Musiani
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

9.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

10.  Thymus cell maturation. Studies on the origin of cortisone-resistant thymic lymphocytes.

Authors:  I L Weissman
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Functional histology of the human thymus.

Authors:  B von Gaudecker
Journal:  Anat Embryol (Berl)       Date:  1991

2.  Cells immunoreactive for neuropeptide in human thymomas.

Authors:  L Lauriola; N Maggiano; L M Larocca; F O Ranelletti; R Ricci; M Piantelli; A Capelli
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

3.  Antibodies to acetylcholine receptors in patients with different clinical forms of myasthenia and Lambert-Eaton myasthenic syndrome.

Authors:  D V Sidnev; M Yu Karganov; N I Shcherbakova; I B Alchinova; A G Sanadze
Journal:  Neurosci Behav Physiol       Date:  2007-02

Review 4.  Functional anatomy of the thymic microenvironment.

Authors:  M D Kendall
Journal:  J Anat       Date:  1991-08       Impact factor: 2.610

Review 5.  Tumours of the thymus and their nomenclature.

Authors:  H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Authors:  N Sommer; B Sigg; A Melms; M Weller; K Schepelmann; V Herzau; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

7.  Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies.

Authors:  N Nagvekar; L W Jacobson; N Willcox; A Vincent
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

8.  A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

Authors:  N Nagvekar; A M Moody; P Moss; I Roxanis; J Curnow; D Beeson; N Pantic; J Newsom-Davis; A Vincent; N Willcox
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

9.  Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.

Authors:  A Marx; T Kirchner; F Hoppe; R O'Connor; B Schalke; S Tzartos; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

10.  Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours.

Authors:  Marco Chilosi; Alberto Zamò; Antonietta Brighenti; Giorgio Malpeli; Licia Montagna; Paola Piccoli; Serena Pedron; Maurizio Lestani; Giorgio Inghirami; Aldo Scarpa; Claudio Doglioni; Fabio Menestrina
Journal:  Virchows Arch       Date:  2003-07-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.